HIGHLY GLYCOSYLATED LONG-ACTING HUMAN GROWTH HORMONE PROTEIN AND PRODUCTION METHOD FOR SAME
World Intellectual Property Organization Patent
Stats

Importance

WO Family Size
|
Non-US Coverage
|
Abstract
The present invention relates to a long-acting human growth hormone NexP-hGH protein which is highly glycosylated and highly long acting in vivo, and relates to a production method for same. More specifically, the present invention relates to a specific isoform of long-acting human growth hormone NexP-hGH protein in which human growth hormone is fused with a highly glycosylated alpha-1 antitrypsin mutant whereby long-acting properties in vivo are increased, and relates to a production method for same. Insofar as the sustained human growth hormone production method is concerned, the present invention also relates to a high-purity purification method for NexP-hGH, the method specifically comprising the steps of: (a) carrying out anion-exchange resin chromatography on a biological emulsion comprising NexP-hGH which is a long-acting human growth hormone in which human growth hormone is fused with an alpha-1 antitrypsin mutant; (b) carrying out hydrophobic resin chromatography on the biological emulsion comprising NexP-hGH, or on the eluate produced in step (a); and (c) carrying out affinity chromatography, entailing packing with a resin to which anti alpha-1 antitrypsin antibody fragments are attached, on the biological emulsion comprising NexP-hGH which is a long-acting human growth hormone, and on the eluate produced in step (a) or step (b).

First Claim
Family

- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Country Designations

Patent Owner(s)
Patent Owner | Address |
---|---|
CJ CHEILJEDANG CORP | KRSEOUL SOUTH KEREAN SEOUL |
International Classification(s)
Inventor(s)
Inventor Name | Address |
---|---|
PARK CHI HYE | SEONGNAM-SI GYEONGGI-DO 463-776 |
LEE SANG MEE | DAEJEON 305-340 |
PARK SOON JAE | DAEJEON 34054 |
LEE SANG HYUN | 07793 서울특별시 강서구 마곡동로 110 SEOUL 07793 |
PARK YOUNG JOON | 02831 서울특별시 성북구 성북로4길 52 205동 2101호 SEOUL 02831 |
LEE DONG EOK | SEOUL 138-764 |
CHUNG HYE SHIN | DAEJEON 305-759 |
KANG GIL BU | BUSAN 614-010 |
LEE CHUNG MIN | 16229 경기도 수원시 영통구 창룡대로 260 11층 GYEONGGI-DO 16229 |
AHN JEE WON | SEOUL 137-818 |
JUN CHANG BONG | GOYANG-SI GYEONGGI-DO 410-350 |
LEE WON JEONG | SEOUL 138-200 |
CHO SUNG YOO | SEONGNAM-SI GYEONGGI-DO 463-823 |
KIM KI WAN | DAEGU |
OH HOO KEUN | SUWON-SI GYEONGGI-DO 441-763 |
MOON JI HYUN | 15588 경기도 안산시 상록구 한양대학로 55 15588 |
LEE YOON JUNG | SEOUL |
LIM HYOUNG TAEK | BUPYEONG-GU INCHEON 21384 |
Cited Art Landscape
- No Cited Art to Display

Full Text

Legal Events

Matter Detail

Renewals Detail

Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:

Add to additional portfolios:

Note
The template below is formatted to ensure compatibility with our system.
Provide tags with | separated like (tags1|tags2).
Maximum length is 128 characters for Customer Application No
Mandatory Fields * - 'MatterType','AppType','Country','Title','SerialNo'.
Acceptable Date Format - 'MM/DD/YYYY'.
Acceptable Filing/App Types -
- Continuation/Divisional
- Original
- Paris Convention
- PCT National
- With Priority
- EP Validation
- Provisional Conversion
- Reissue
- Provisional
- Foreign Extension
Acceptable Status -
- Pending
- Abandoned
- Unfiled
- Expired
- Granted
Acceptable Matter Types -
- Patent
- Utility Model
- Supplemental Protection Certificate
- Design
- Inventor Certificate
- Plant
- Statutory Invention Reg
Advertisement
Advertisement
Advertisement

Recipient Email Address

Recipient Email Address

Comment
Recipient Email Address

Success
E-mail has been sent successfully.
Failure
Some error occured while sending email. Please check e-mail and try again!
Important Notes on Latency of Status data
This Status indicator is an estimation based on the relevant document kind code. As such, it status will only indicate "Published" or "Granted". Expired, lapsed or abandoned statuses are not available in this release. Please refer to the legal status information for more information.
This status should not be taken as legal conclusion. No representations are made as to the accuracy of the status provided. Please consult a legal professional before relying on this status information.
Important Note on Priority Date data
This priority date is an estimated earliest priority date and is purely an estimation. This date should not be taken as legal conclusion. No representations are made as to the accuracy of the date listed. Please consult a legal professional before relying on this date.
Only for Granted EP cases
EP validations represent the countries in which the EP patent may be in force. Data is based on reporting from the various EP contracting states. The reporting consistency can vary across the countries.